ESC Professional Premium Access

Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts

Topic: Cardiotoxicity of Drugs and Other Therapies

Congress Presentation

About the speaker

Associate Professor Konrad Urbanek

University of Naples Federico II, Naples (Italy)
0 follower

6 more presentations in this session

Pre-diabetes is associated with increased cardiac events in cancer patients prescribed anthracyclines

Speaker: Doctor I. Cheang (Nanjing, CN)


Prognostic value of 6-minute walking test for early prediction of doxorubicin induced cardiotoxicity

Speaker: Mrs G. Muckiene (Kaunas, LT)


Usefulness of the baseline risk assessment guidelines to predict cancer therapy-related cardiac dysfunction in early-stage HER2 positive breast cancer

Speaker: Doctor G. Oristrell Santamaria (Barcelona, ES)


CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicity

Speaker: Doctor T. Kretzschmar (Jena, DE)


Effect of vitamin D receptor genetic polymorphism on the clinical response to angiotensin converting enzyme inhibitors therapy among breast cancer patients with chemotherapy induced cardiomyopathy

Speaker: Miss I. Al-Ansary (Cairo, EG)


Access the full session

Cardiotoxicity of drugs and other therapies

Speakers: Associate Professor K. Urbanek, Doctor I. Cheang, Mrs G. Muckiene, Doctor G. Oristrell Santamaria, Doctor T. Kretzschmar...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by